10-K/A: BioRestorative Therapies Files Amendment to 10-K, Details Share Structure and Anti-Takeover Provisions

BioRestorative Therapies, Inc. filed an amendment to its annual report to include a description of its securities and anti-takeover provisions.

Summary

• BioRestorative Therapies, Inc. has filed an amendment to its annual report on Form 10-K/A to include Exhibit 4.1, which describes the company's securities registered under Section 12 of the Securities Exchange Act of 1934.
• The company has one class of securities registered: common stock with a par value of $0.0001 per share.
• As of November 5, 2024, the company had 6,919,919 shares of common stock issued and outstanding.
• The company is authorized to issue 75,000,000 shares of common stock and 20,000,000 shares of preferred stock, with a par value of $0.01 per share for preferred stock.
• Common stockholders are entitled to dividends as declared by the Board of Directors and have one vote per share.
• The document outlines provisions in Nevada law and the company's charter and bylaws that could delay or prevent takeover attempts, including those related to combinations with interested stockholders and control share acquisitions.
• The company has not opted out of the Nevada control share acquisitions statute.
• The Board of Directors is authorized to issue preferred stock without stockholder approval, which could also delay or prevent a change in control.
• The company has a classified Board of Directors, which makes changes in the board composition more difficult.
• Special meetings of stockholders can only be called by the Board of Directors or the Chairman of the Board.
• Stockholders can remove directors with or without cause with a 75% vote.
• Amendments to the bylaws and certain charter provisions also require a 75% vote.
• The bylaws include advance notice procedures for stockholder nominations and proposals.

Sentiment

Score: 6

Explanation: The document is a factual disclosure of the company's share structure and governance, with no significant positive or negative news. The anti-takeover provisions are a mixed bag, providing stability but potentially limiting shareholder value.

Positives

• The company has a clear structure for its common stock, including dividend and voting rights.
• The board has the flexibility to issue preferred stock to raise capital or for other corporate purposes.
• The company has implemented measures to ensure stability and continuity in the board and management.

Negatives

• The anti-takeover provisions could make it difficult for shareholders to benefit from a potential acquisition.
• The classified board structure could entrench current management.
• The high voting threshold for removing directors and amending bylaws could limit shareholder influence.

Risks

• The anti-takeover provisions could deter potential acquirers, potentially limiting shareholder value.
• The board's ability to issue preferred stock without shareholder approval could dilute existing shareholders' equity.
• The classified board structure could make it difficult for shareholders to effect change in the company's direction.
• The high voting thresholds for certain actions could make it difficult for shareholders to influence corporate governance.

Management Comments

• Lance Alstodt, the Principal Executive Officer, certified that the report does not contain any untrue statement of a material fact.
• Robert Kristal, the Principal Financial Officer, certified that the report does not contain any untrue statement of a material fact.

Industry Context

This filing is a standard regulatory disclosure for a publicly traded company, detailing its capital structure and governance mechanisms. The anti-takeover provisions are common among public companies to protect against hostile takeovers.

Comparison to Industry Standards

• The authorized share structure is typical for a company of this size and stage.
• The anti-takeover provisions, such as the classified board and supermajority voting requirements, are common among publicly traded companies, particularly those seeking to maintain control and stability.
• The Nevada control share acquisition statute is a state-specific regulation that impacts the company's takeover defenses.
• Companies like Amgen, Gilead, and Regeneron also have similar anti-takeover provisions in their charters and bylaws, although the specifics may vary.
• The level of detail provided in the description of securities is consistent with SEC requirements for public companies.

Corporate Governance

Stakeholder Impact

• Shareholders may be impacted by the anti-takeover provisions, which could limit their ability to benefit from a potential acquisition.
• The board's ability to issue preferred stock without shareholder approval could dilute existing shareholders' equity.
• The classified board structure could make it difficult for shareholders to effect change in the company's direction.
• The high voting thresholds for certain actions could make it difficult for shareholders to influence corporate governance.

Key Dates

Keywords

common stock, preferred stock, anti-takeover, corporate governance, voting rights, board of directors, shareholder rights, Nevada law, capital stock, securities